ARHGEF4 Regulates an Essential Oncogenic Program in t(12;21)-Associated Acute Lymphoblastic Leukemia

por Virely, Clemence, Gasparoli, Luca, Mangolini, Maurizio, Clesham, Katherine, Inglott, Sarah, Edwards, Darren, Adams, Stuart, Bartram, Jack, Samarasinghe, Sujith, Ancliff, Philip, Vora, Ajay, de Boer, Jasper, Williams, Owen
Publicado 2020

Identification of a c-MYB-directed therapeutic for acute myeloid leukemia

por Clesham, Katherine, Walf-Vorderwülbecke, Vanessa, Gasparoli, Luca, Virely, Clemence, Cantilena, Sandra, Tsakaneli, Alexia, Inglott, Sarah, Adams, Stuart, Samarasinghe, Sujith, Bartram, Jack, Williams, Gareth, de Boer, Jasper, Williams, Owen
Publicado 2022

Combined Targeting of JAK2 and Bcl-2/Bcl-xL to Cure Mutant JAK2-Driven Malignancies and Overcome Acquired Resistance to JAK2 Inhibitors

por Waibel, Michaela, Solomon, Vanessa S., Knight, Deborah A., Ralli, Rachael A., Kim, Sang-Kyu, Banks, Kellie-Marie, Vidacs, Eva, Virely, Clemence, Sia, Keith C.S., Bracken, Lauryn S., Collins-Underwood, Racquel, Drenberg, Christina, Ramsey, Laura B., Meyer, Sara C., Takiguchi, Megumi, Dickins, Ross A., Levine, Ross, Ghysdael, Jacques, Dawson, Mark A., Lock, Richard B., Mullighan, Charles G., Johnstone, Ricky W.
Publicado 2013